SCHEMBL21392851

SCHEMBL21392851

C=CC(=O)N1CCc2cc(OCC)ccc2C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.50
TET3 O43151 3/20 0.50
FBXL19 Q6PCT2 3/20 0.50
TET1 Q8NFU7 3/20 0.50
KDM2B Q8NHM5 3/20 0.50
CXXC4 Q9H2H0 3/20 0.50
KDM2A Q9Y2K7 3/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
CXXC5 Q7LFL8 2/20 0.50
RYR2 Q92736 1/20 0.50
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48
ACACB O00763 2/20 0.47
ABHD6 Q9BV23 1/20 0.46
ALOX5 P09917 1/20 0.45
ABCB1 P08183 1/20 0.45
MAPT P10636 2/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24490157 0.81 CYP1A2 (0.45) KMT2ANPC1RAB9ARYR2ESR1
SCHEMBL3893409 0.80 ESR1 (0.75) KMT2ANPC1RAB9AESR1ESR2
SCHEMBL22461208 0.80 MEN1 (0.49) KMT2ARYR2ESR1ESR2ABCB1
SCHEMBL10312979 0.79 HRH3 (0.67) KMT2ANPC1RAB9AACACBALOX5
SCHEMBL14781510 0.79 ESR2 (0.67) KMT2ANPC1RAB9AESR1ESR2
SCHEMBL22460958 0.79 RYR2 (0.47) KMT2ANPC1RAB9ARYR2ESR1
SCHEMBL30924689 0.79 HRH3 (0.57) NPC1RAB9APOLBHRH3BTK
SCHEMBL27229575 0.79 HRH3 (0.57) NPC1RAB9APOLBHRH3BTK
SCHEMBL24490162 0.79 RYR2 (0.52) KMT2ATET3FBXL19TET1KDM2B
SCHEMBL25543001 0.79 MAPT (0.51) KMT2ANPC1RAB9ARYR2ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
WO-2019183600-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-09-26 WO disclosed
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY FRONTIER MEDICINES CORPORATION 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY ATG7, BECN1, SQSTM1 KMT2A 3168/4885TET3 4087/4885FBXL19 2571/4885
US-11666661-B2 Methods and compounds for targeted autophagy ATG7, BECN1, SQSTM1 KMT2A 3168/4885TET3 4087/4885FBXL19 2571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.